Aiming for a “Cure” for Hepatitis B: China’s New Drug Gains FDA Clinical Approval

Introduction: This milestone marks another solid step forward for China in the field of innovative drug development for hepatitis B. Hepatitis B, as a global public health challenge, has plagued hundreds of millions of patients for decades. While current therapies…




